News

Open post for "Disease Model Development Manager"


A post-doc associate will be required to develop a deeper understanding of the relevance of in vivo Drosophila models to study pathologies of disease, as well as to develop novel models. She/he will also develop and implement novel phenotypic assays and be responsible for establishing, and day to day maintenance of a dedicated Drosophila facility. The candidate will have access to state-of-the-art facilities and work in an international and interdisciplinary setting.

Required profile:
- Recognised Researcher R2 (European Framework for Research Career)
- PhD
- Demonstrated expertise
- Comply with the Transnational mobility criteria (the researcher must come from a different country than the place of employment)

Send your resume before 31.5.2017 to #EM#696f646c4464656e6d7a686263236d607d#EM# and add to subject “Disease Model Development Manager”.





ABCloneTM is fast and efficient solution for cloning of large natural and synthetic DNA fragments. We provide ABCloneTM as a stand alone service for getting quickly your long DNA fragment sub-cloned into plasmid vector of your choice.

More >>
European Medicines Agency (EMA) granted orphan medicinal product designation to its lead compound CAB1803 for Pantothenate-kinase-associated neurodegeneration (PKAN)

More >>
Scientists at ACIES BIO made a breakthrough innovation: high-value technology that uses unique and economic bioprocess to convert acid waste whey from dairy factories into high value animal feed products (vitamin B12) and clean water in the same process. Check out Whey2Value!



More >>
Within H2020 SME Innovation Associate project we invite a “Disease Model Development Manager” to join our team.




More >>
Acies Bio received the “Jesenko Award” from Biotechnical Faculty of University of Ljubljana. The award recognizes institutions for their outstanding research work in the field of biotechnology.